LITERATURE

REFERENCES

1. Ferreri AJM, Cecchetti C, Kiesewetter B, et al. Clarithromycin as a "repurposing drug" against MALT lymphoma. Br J Haematol. 2018;182(6):913–915. doi:10.1111/bjh.14878.

2. Kiesewetter B, Dolak W, Mayerhoefer ME, Simonitsch-Klupp I, Raderer M. Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum. Case Rep Oncol. 2018;11(1):239–245. Published 2018 Apr 11. doi:10.1159/000488388.

3. Mark TM, Coleman M. It's Time to Take Clarithromycin Seriously in Multiple Myeloma. Acta Haematol. 2016;135(2):101–102. doi:10.1159/000440874.

4. Cramer CL, Patterson A, Alchakaki A, Soubani AO. Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. Postgrad Med. 2017;129(5):493–499. doi:10.1080/00325481.2017.1285677

5. Martin, J.R. US Patent 3,684,794. 3-O-(.alpha.-L-mycarosyl-8-hydroxyerythronolide B .1972.

6. Mendel M, Chłopecka M, Dziekan N, Karlik W. Interactions between erythromycin, flunixin meglumine, levamisole and plant secondary metabolites towards bovine gastrointestinal motility-in vitro study. J Vet Pharmacol Ther. 2018;41(2):281–291. doi:10.1111/jvp.12455.

7. Huckle AW, Fairclough LC, Todd I. ProphylacticAntibiotic Use in COPD and the Potential Anti-Inflammatory Activities of Antibiotics. Respir Care. 2018;63(5):609–619. doi:10.4187/respcare.05943

8. Chiang LH, Wu TH, Tsai TC, Lee WC. Coadministration of Erythromycin to Increase Tacrolimus Concentrations in Liver Transplant Recipients. Transplant Proc. 2019;51(5):1439–1441. doi:10.1016/j.transproceed.2019.01.145

9 Jain R, Danziger LH. The macrolide antibiotics:a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des. 2004;10(25):3045–3053. doi:10.2174/1381612043383322